tradingkey.logo
tradingkey.logo
Pesquisar

SI-BONE Inc

SIBN
Adicionar à lista de desejos
17.110USD
+0.310+1.85%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
758.82MValor de mercado
PerdaP/L TTM

Mais detalhes de SI-BONE Inc Empresa

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Informações de SI-BONE Inc

Código da empresaSIBN
Nome da EmpresaSI-BONE Inc
Data de listagemOct 17, 2018
CEOFrancis (Laura A)
Número de funcionários349
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 17
Endereço471 El Camino Real, Suite 101
CidadeSANTA CLARA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal95050
Telefone14082070700
Sitehttps://si-bone.com/
Código da empresaSIBN
Data de listagemOct 17, 2018
CEOFrancis (Laura A)

Executivos da empresa SI-BONE Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
172.06K
+1.79%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
87.64K
+8.42%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
58.24K
-8.01%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
35.10K
+31.22%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
35.00K
+31.31%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
20.11K
+54.47%
Ms. Laura A. Francis
Ms. Laura A. Francis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Michael A. Pisetsky
Mr. Michael A. Pisetsky
Secretary, Chief Business & Legal Affairs Officer
Secretary, Chief Business & Legal Affairs Officer
--
--
Mr. Anthony J. Recupero, Ph.D.
Mr. Anthony J. Recupero, Ph.D.
President - Commercial Operations
President - Commercial Operations
--
--
Mr. Timothy E. (Ted) Davis, Jr.
Mr. Timothy E. (Ted) Davis, Jr.
Lead Independent Director
Lead Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
172.06K
+1.79%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
87.64K
+8.42%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
58.24K
-8.01%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
35.10K
+31.22%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
35.00K
+31.31%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
20.11K
+54.47%

Perguntas frequentes

Quem são os cinco principais acionistas de SI-BONE Inc?

Os cinco principais acionistas de SI-BONE Inc são: Mr. Gregory K. (Greg) Hinckley, CPA

Quantas instituições possuem ações da SI-BONE Inc (SIBN)?

Em 2026Q1, 367 instituições possuíam ações da SI-BONE Inc, com valor de mercado aproximado de 45.75M, representando 103.63% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -2298649.00.